Skip to main content
Top
Gepubliceerd in:

20-06-2015

Turkish version of the Drug Hypersensitivity Quality of Life Questionnaire: assessment of reliability and validity

Auteurs: Sevim Bavbek, Seçil Kepil Özdemir, Beyza Doğanay Erdoğan, Işıl Karaboğa, Suna Büyüköztürk, Aslı Gelincik, İnsu Yılmaz, Özlem Göksel, Adile Berna Dursun, Gül Karakaya, Ali Fuat Kalyoncu, Ferhan Özşeker, Gülden Paşaoğlu Karakış, Ferda Öner Erkekol, Gözde Köycü, Metin Keren, Ilaria Baiardini, Antonino Romano

Gepubliceerd in: Quality of Life Research | Uitgave 1/2016

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

The first disease-specific quality-of-life questionnaire in patients with drug hypersensitivity, Drug Hypersensitivity Quality of Life Questionnaire (DrHy-Q), was developed and validated recently. The aim of this study was to assess validity, reliability and responsiveness to interventions of the Turkish version of the DrHy-Q.

Methods

The Turkish version of the DrHy-Q was administered to prospectively enrolled 736 patients with drug hypersensitivity from ten allergy units. To assess validity, all patients completed the validated Turkish version of Psychological General Well-Being Index (PGWBI). For test–retest reliability, 182 patients completed the DrHy-Q 1 week after the first questionnaire administration without any intervention. Responsiveness was assessed on 97 patients who had a DrHy-Q recorded at a follow-up visit after the intervention.

Results

The internal consistency and test–retest reliability of the scale were adequate (Cronbach’s alpha = 0.934, intra-class correlation coefficient = 0.783). The DrHy-Q scores showed weak negative correlations with the PGWBI total and domain scores (r = − 0.378 to −0.254, p < 0.001). DrHy-Q was able to discriminate the patients with one drug hypersensitivity reaction from the patients with two and above two reactions (p = 0.012 and p < 0.001, respectively), and the patients who experienced a respiratory reaction from the patients who did not (p = 0.018). However, it did not discriminate the patients with comorbid disease including psychiatric comorbidity (p > 0.05). The baseline DrHy-Q scores were significantly higher than the post-intervention scores (p = 0.008).

Conclusion

The Turkish version of DrHy-Q is reliable and valid for evaluating quality of life in patients with drug hypersensitivity, and it appeared responsive to interventions.
Literatuur
1.
go back to reference Baiardini, I., Pasquali, M., Giardini, A., Specchia, C., Passalacqua, G., Venturi, S., et al. (2003). Rhinasthma: A new specific QoL questionnaire for patients with rhinitis and asthma. Allergy, 38, 289–294.CrossRef Baiardini, I., Pasquali, M., Giardini, A., Specchia, C., Passalacqua, G., Venturi, S., et al. (2003). Rhinasthma: A new specific QoL questionnaire for patients with rhinitis and asthma. Allergy, 38, 289–294.CrossRef
2.
go back to reference Gomes, E., Cardoso, M. F., Praça, F., Gomes, L., Mariño, E., & Demoly, P. (2004). Self-reported drug allergy in a general Portuguese population. Clinical and Experimental Allergy, 34, 1597–1601.PubMedCrossRef Gomes, E., Cardoso, M. F., Praça, F., Gomes, L., Mariño, E., & Demoly, P. (2004). Self-reported drug allergy in a general Portuguese population. Clinical and Experimental Allergy, 34, 1597–1601.PubMedCrossRef
3.
go back to reference Demoly, P., Adkinson, N. F., Brockow, K., Castells, M., Chiriac, A. M., Greenberger, P. A., et al. (2014). International consensus on drug allergy. Allergy, 69, 420–437.PubMedCrossRef Demoly, P., Adkinson, N. F., Brockow, K., Castells, M., Chiriac, A. M., Greenberger, P. A., et al. (2014). International consensus on drug allergy. Allergy, 69, 420–437.PubMedCrossRef
4.
go back to reference Bavbek, S., Erkekol, F. Ö., Celik, G. E., Gönüllü, I., & Misirligil, Z. (2011). Self-reported prevalence of hypersensitivity reactions against drugs among medical students: Does awareness cause any difference? Pharmacoepidemiology and Drug Safety, 20(2), 154–161.PubMedCrossRef Bavbek, S., Erkekol, F. Ö., Celik, G. E., Gönüllü, I., & Misirligil, Z. (2011). Self-reported prevalence of hypersensitivity reactions against drugs among medical students: Does awareness cause any difference? Pharmacoepidemiology and Drug Safety, 20(2), 154–161.PubMedCrossRef
5.
go back to reference Bavbek, S., Celik, E. G., Aydın, O., Oner Erkekol, F., Kursun, N., Mungan, D., et al. (2012). Prevalence of hypersensitivity reactions against drugs among adult population in Turkey: A self reported survey. Journal of Public Health, 20, 585–592.CrossRef Bavbek, S., Celik, E. G., Aydın, O., Oner Erkekol, F., Kursun, N., Mungan, D., et al. (2012). Prevalence of hypersensitivity reactions against drugs among adult population in Turkey: A self reported survey. Journal of Public Health, 20, 585–592.CrossRef
6.
go back to reference Bavbek, S., Pasaoğlu, G., Canat, S., Sağduyu, G., & Mısırlığıl, Z. (2006). Allergy to drugs: How important for psychological epidemiology? International Journal on Psychiatry in Clinical Practice, 10(1), 64–68.CrossRef Bavbek, S., Pasaoğlu, G., Canat, S., Sağduyu, G., & Mısırlığıl, Z. (2006). Allergy to drugs: How important for psychological epidemiology? International Journal on Psychiatry in Clinical Practice, 10(1), 64–68.CrossRef
7.
go back to reference Baiardini, I., Braido, F., Fassio, O., Calia, R., Canonica, G. W., Romano, A., & DrHy-Q PROs Research Italian Group. (2011). Development and validation of the Drug Hypersensitivity Quality of Life Questionnaire. Annals of Allergy, Asthma & Immunology, 106, 330–335.CrossRef Baiardini, I., Braido, F., Fassio, O., Calia, R., Canonica, G. W., Romano, A., & DrHy-Q PROs Research Italian Group. (2011). Development and validation of the Drug Hypersensitivity Quality of Life Questionnaire. Annals of Allergy, Asthma & Immunology, 106, 330–335.CrossRef
8.
go back to reference Testa, M. A., & Simonson, D. C. (1996). Assessment of quality-of-life outcomes. New England Journal of Medicine, 334, 835–840.PubMedCrossRef Testa, M. A., & Simonson, D. C. (1996). Assessment of quality-of-life outcomes. New England Journal of Medicine, 334, 835–840.PubMedCrossRef
9.
go back to reference Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297–334.CrossRef Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297–334.CrossRef
10.
go back to reference Streiner, D. L., & Norman, G. R. (1995). Health measurement scales. A practical guide to their development and use (2nd ed., pp. 104–126). New York: Oxford Medical Publications. Streiner, D. L., & Norman, G. R. (1995). Health measurement scales. A practical guide to their development and use (2nd ed., pp. 104–126). New York: Oxford Medical Publications.
11.
go back to reference Fleiss, J. L., Levin, B., & Paik, M. C. (2003). Statistical methods for rates and proportions. Hoboken, NJ: Wiley.CrossRef Fleiss, J. L., Levin, B., & Paik, M. C. (2003). Statistical methods for rates and proportions. Hoboken, NJ: Wiley.CrossRef
12.
go back to reference Ay, S., Koldaş Doğan, Ş., Evcik, D., Gök, H., Tur, B. S., & Gökmen, D. (2010). Reliability and validity of psychological general well-being index in Turkish population. Turkish Journal of Physical Medicine and Rehabilitation, 56, 161–169. Ay, S., Koldaş Doğan, Ş., Evcik, D., Gök, H., Tur, B. S., & Gökmen, D. (2010). Reliability and validity of psychological general well-being index in Turkish population. Turkish Journal of Physical Medicine and Rehabilitation, 56, 161–169.
13.
go back to reference Dupuy, H. (1984). The psychological general well-being (PGWB) index. In N. K. Wenger, M. E. Mattson, C. D. Furberg, & J. Elinson (Eds.), Assessment of quality of life in clinical trials of cardiovascular therapies (pp. 170–183). Greenwich, CT: Le Jacq Publishing Inc. Dupuy, H. (1984). The psychological general well-being (PGWB) index. In N. K. Wenger, M. E. Mattson, C. D. Furberg, & J. Elinson (Eds.), Assessment of quality of life in clinical trials of cardiovascular therapies (pp. 170–183). Greenwich, CT: Le Jacq Publishing Inc.
14.
go back to reference Ertam, I., Kitapcioglu, G., Aksu, K., et al. (2009). Quality of life and its relation with disease severity in Behçet’s disease. Clinical and Experimental Rheumatology, 27, S18–S22.PubMed Ertam, I., Kitapcioglu, G., Aksu, K., et al. (2009). Quality of life and its relation with disease severity in Behçet’s disease. Clinical and Experimental Rheumatology, 27, S18–S22.PubMed
15.
go back to reference Pallant, J. F., Kenan, A. M., Misajon, R., Conaghan, P. G., & Tennant, A. (2009). Measuring the impact and distress of osteoarthritis from the patients’ perspective. Health and Quality of Life Outcomes, 29(7), 37.CrossRef Pallant, J. F., Kenan, A. M., Misajon, R., Conaghan, P. G., & Tennant, A. (2009). Measuring the impact and distress of osteoarthritis from the patients’ perspective. Health and Quality of Life Outcomes, 29(7), 37.CrossRef
16.
go back to reference Pai, A. L., Mullins, L. L., Drotar, D., Burant, C., Wagner, J., & Chaney, J. M. (2007). Exploratory and confirmatory factor analysis of the child uncertainty in illness scale among children with chronic illness. Journal of Pediatric Psychology, 32, 288–296.PubMedCrossRef Pai, A. L., Mullins, L. L., Drotar, D., Burant, C., Wagner, J., & Chaney, J. M. (2007). Exploratory and confirmatory factor analysis of the child uncertainty in illness scale among children with chronic illness. Journal of Pediatric Psychology, 32, 288–296.PubMedCrossRef
17.
go back to reference Copay, A. G., Subach, B. R., Glassman, S. D., Polly, D. W, Jr, & Schuler, T. C. (2007). Understanding the minimum clinically important difference: A review of concepts and methods. The Spine Journal, 7, 541–546.PubMedCrossRef Copay, A. G., Subach, B. R., Glassman, S. D., Polly, D. W, Jr, & Schuler, T. C. (2007). Understanding the minimum clinically important difference: A review of concepts and methods. The Spine Journal, 7, 541–546.PubMedCrossRef
18.
go back to reference Cohen, J. (1977). Statistical power: Analysis for behavioral sciences. New York: Academic Press. Cohen, J. (1977). Statistical power: Analysis for behavioral sciences. New York: Academic Press.
19.
go back to reference Muthen, L. K., & Muthen, B. O. (1998–2007). Mplus user’s guide, 5th edn. Los Angeles, CA: Muthen and Muthen. Muthen, L. K., & Muthen, B. O. (1998–2007). Mplus user’s guide, 5th edn. Los Angeles, CA: Muthen and Muthen.
21.
go back to reference Baiardini, I., Bousquet, P. J., Brzoza, Z., Canonica, G. W., Compalati, E., Fiocchi, A., et al. (2010). Global allergy and asthma European network. Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: A GA(2)LEN task force position paper. Allergy, 65(3), 290–295.PubMedCrossRef Baiardini, I., Bousquet, P. J., Brzoza, Z., Canonica, G. W., Compalati, E., Fiocchi, A., et al. (2010). Global allergy and asthma European network. Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: A GA(2)LEN task force position paper. Allergy, 65(3), 290–295.PubMedCrossRef
22.
go back to reference Smith, K. W., Avis, N. E., & Assmann, S. F. (1999). Distinguishing between quality of life and health status in quality of life research: A metaanalysis. Quality of Life Research, 8, 447–459.PubMedCrossRef Smith, K. W., Avis, N. E., & Assmann, S. F. (1999). Distinguishing between quality of life and health status in quality of life research: A metaanalysis. Quality of Life Research, 8, 447–459.PubMedCrossRef
23.
go back to reference Simons, F. E., Ardusso, L. R., Bilò, M. B., El-Gamal, Y. M., Ledford, D. K., Ring, J., et al. (2011). World Allergy Organization anaphylaxis guidelines: Summary. Journal of Allergy and Clinical Immunology, 127, 587–593.PubMedCrossRef Simons, F. E., Ardusso, L. R., Bilò, M. B., El-Gamal, Y. M., Ledford, D. K., Ring, J., et al. (2011). World Allergy Organization anaphylaxis guidelines: Summary. Journal of Allergy and Clinical Immunology, 127, 587–593.PubMedCrossRef
Metagegevens
Titel
Turkish version of the Drug Hypersensitivity Quality of Life Questionnaire: assessment of reliability and validity
Auteurs
Sevim Bavbek
Seçil Kepil Özdemir
Beyza Doğanay Erdoğan
Işıl Karaboğa
Suna Büyüköztürk
Aslı Gelincik
İnsu Yılmaz
Özlem Göksel
Adile Berna Dursun
Gül Karakaya
Ali Fuat Kalyoncu
Ferhan Özşeker
Gülden Paşaoğlu Karakış
Ferda Öner Erkekol
Gözde Köycü
Metin Keren
Ilaria Baiardini
Antonino Romano
Publicatiedatum
20-06-2015
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 1/2016
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-015-1051-2

Andere artikelen Uitgave 1/2016

Quality of Life Research 1/2016 Naar de uitgave